ProMIS Neurosciences (PMN) Interest Coverage Ratio (2021 - 2026)

ProMIS Neurosciences' (PMN) quarterly Interest Coverage Ratio came in at 120.81 in Q1 2026, down 45747.61% on a QoQ basis from 0.26 in Q4 2025.

ProMIS Neurosciences (PMN) Interest Coverage Ratio (2021 - 2026) Analysis & Trends

ProMIS Neurosciences (PMN) has 6 years of Interest Coverage Ratio data on file, last reported at 120.81 in Q1 2026.

Quarterly Interest Coverage Ratio changed N/A year-over-year to 120.81 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 578.32 (down 327.08% YoY) and the FY2025 annual result came in at 0.98, down 85.75% from the prior year.
Interest Coverage Ratio fell to 120.81 in Q1 2026, from 0.26 in the prior quarter.
In the past five years, Interest Coverage Ratio ranged from a high of 0.26 in Q4 2025 to a low of 1250.34 in Q3 2022.
A 5-year average of 174.52 and a median of 41.12 in 2024 frame the typical range for Interest Coverage Ratio.
Annual changes were most pronounced in 2022 — Interest Coverage Ratio tumbled 8407.87% — and 2023, when it surged 97.33%.
Tracing PMN's Interest Coverage Ratio over 5 years: stood at 1250.34 in 2022, then soared by 95.96% to 50.45 in 2023, then sank by 449.34% to 277.17 in 2024, then surged by 99.9% to 0.26 in 2025, then tumbled by 45747.61% to 120.81 in 2026.
The last three Interest Coverage Ratio figures came in at 120.81 (Q1 2026), 0.26 (Q4 2025), and 277.17 (Q3 2024), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Interest Cover (Qtr)
1	Vertex Pharmaceuticals	140.29 Bn	132.43 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	86.58 Bn	78.58 Bn	3.93 Bn	117.59
3	Argenx Se	65.26 Bn	60.08 Bn	1.37 Bn	-
4	Moderna	61.87 Bn	56.73 Bn	52.00 Mn	-
5	BeOne Medicines	42.18 Bn	37.08 Bn	1.53 Bn	8.18
6	Alnylam Pharmaceuticals	31.51 Bn	28.20 Bn	992.69 Mn	2.82
7	BioNTech SE	28.90 Bn	10.51 Bn	668.28 Mn	76.86
8	Insmed	27.46 Bn	26.30 Bn	358.27 Mn	-0.08
9	Royalty Pharma	27.24 Bn	26.41 Bn	-	1.42
10	ProMIS Neurosciences	135.63 Mn	82.16 Mn	-	-

Download Data